Scarica l'app Stockscreener
16.73
1.06%
-0.18
Pre-mercato:
16.78
0.05
+0.30%
Theravance Biopharma Inc Borsa (TBPH) Ultime notizie
MSN Money - MSN
(TBPH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Theravance's Q4 earnings and revenues miss estimates - MSN
Theravance stock declines around 17% in three months: Here's why - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc.TBPH - PR Newswire
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc.TBPH - FinancialContent
Theravance Biopharma (NASDAQ: TBPH) sets 2026 AGM votes on board, pay, auditor - Stock Titan
A Pivotal Quarter for Theravance Biopharma (TBPH): Milestone Cash Influx and a Transition to Pure Commercial Play - AlphaStreet
Theravance Biopharma (TBPH) Q4 earnings and revenues lag estimates - MSN
Here's why Theravance Biopharma (TBPH) is a strong momentum stock - MSN
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Laughing Water Capital Adds Theravance Biopharma to Portfolio in Q1 2026 - HarianBasis.co
Laughing Water Capital’s New Position: Theravance Biopharma, Inc. (TBPH) - Insider Monkey
Laughing Water Capital’s New Position: Theravance Biopharma (TBPH) - Yahoo Finance
Theravance and Mylan settle patent dispute with Eugia Pharma - MSN
How (TBPH) Movements Inform Risk Allocation Models - Stock Traders Daily
Theravance Biopharma (NASDAQ:TBPH) Shares Pass Below 200 Day Moving AverageHere's What Happened - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Theravance Biopharma, Inc. (TBPH) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Theravance Biopharma, Inc. (TBPH) And Encourages Shareholders to Reach Out - ACCESS Newswire
Theravance Biopharma: A Special Situation With A 50-100% Likely Upside (TBPH) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Theravance Biopharma, Inc. (TBPH) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Theravance Biopharma (TBPH) Stock: What Investors Should Know (-0.75%) 2026-04-20Buy Signals - Xã Thanh Hà
B. Riley Lifts PT on Theravance Biopharma (TBPH) to $17 From $14 - Insider Monkey
Theravance Biopharma, Inc. (TBPH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Theravance Biopharma, Inc. (TBPH) Investigation: Bronstein, Gewir - The National Law Review
Theravance Biopharma, Inc. (TBPH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Theravance Biopharma, Inc. (TBPH) Stock Analysis: Impressive Revenue Growth and Strategic Collaborations Signal Potential Upside - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Is Investigating Theravance Biopharma, Inc. (TBPH) And Encourages Investors to Connect - ACCESS Newswire
Theravance Stock Declines Around 17% in Three Months: Here's Why - Yahoo Finance
TBPH Guided for $75M in Milestones While Trial Risk Went Unquantified -- LEVI & KORSINSKY, LLP - GlobeNewswire
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):